CIK 0001609809
- Non-accelerated filer
- Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 274326290
- Phone
- +1 617-945-9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 4 Open-market sale Shaff Eric D. sold 2,780 shares at $11.02 ($30,636)
- 4 Open-market sale DesRosier Thomas sold 3,475 shares at $11.02 ($38,295)
- 4 Open-market sale Trucksis Michele sold 2,607 shares at $11.02 ($28,729)
- 4 Open-market sale COOK DAVID N sold 1,738 shares at $11.02 ($19,153)
- 4/A Open-market sale Aunins John G. sold 1,623 shares at $10.14 ($16,457)
- 4 Exercise or conversion President and CEO acquired 40,241 shares (option exercise)
- 4 Open-market sale Chief Technology Officer & EVP sold 1,623 shares at $10.14 ($16,457)
- 4 Exercise or conversion President and CEO acquired 100,604 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 19 · 380 filings